Skip to content
Search

Latest Stories

Indians sell family gold to survive the pandemic

Indians sell family gold to survive the pandemic

DESPERATE for cash, many families and small businesses owners in India are selling gold jewellery, their last resort, as collateral to secure short-term loans to survive the Covid cash crunch. 

Business closures and job losses pushed more than 230 million Indians into poverty in the past year, according to a study by Azim Premji University, leaving many struggling to pay rent, school fees and hospital bills.


Their difficulties have been compounded in recent weeks by soaring prices for electricity, fuel and other items.

Banks disbursed "loans against gold jewellery" worth Rs 4.71 trillion ($64 billion) in the first eight months of 2021, a whopping 74 per cent jump year-on-year, central bank data showed.

And many of these loans have gone sour with borrowers unable to keep up with repayments, leaving lenders to auction off the gold. Newspapers have been flooded with notices for such sales.

Gold is considered essential at weddings, birthdays and religious ceremonies in the country, and also seen as a safe asset that can be transferred from one generation to the next.

Indians bought 315.9 tonnes of gold-use jewellery in 2020, almost as much as the Americas, Europe and the Middle East combined, according to the World Gold Council. Only China bought more.

Indian households are estimated to be sitting on 24,000 tons -- worth $1.5 trillion -- in coins, bars and jewellery.

"It is the only social security for the woman or any household because there is no such social security programme from the government," said Dinesh Jain, director at the All India Gem and Jewellery Domestic Council.

"Gold is like liquid cash. You encash it in at any time of the day and night."

Kumar Jain, 63, whose family has run a shop in Mumbai's historic Zaveri Bazaar for 106 years, says he has never seen so many people coming to sell.

"It wasn't like this before the pandemic," he said.

Jain says his customers, predominantly women, have sold a vast array of personal jewellery in recent months including gold bangles, rings, necklaces and earrings.

More For You

pharmacy

The UK spends just 9 per cent of healthcare budgets on medicines while patients face growing access gaps.

iStock

UK calls for new pharmaceutical investment to strengthen life sciences

Highlights

  • UK life sciences sector contributed £17.6bn GVA in 2021 and supports 126,000 high-skilled jobs.
  • Inward life sciences FDI fell by 58 per cent from £1,897m in 2021 to £795m in 2023.
  • Experts warn NHS underinvestment and NICE pricing rules are deterring innovation and patient access.

Investment gap

Britain is seeking to attract new pharmaceutical investment as part of its plan to strengthen the life sciences sector, Chancellor Rachel Reeves said during meetings in Washington this week. “We do need to make sure that we are an attractive place for pharmaceuticals, and that includes on pricing, but in return for that, we want to see more investment flow to Britain,” Reeves told reporters.

Recent ABPI report, ‘Creating the conditions for investment and growth’, The UK’s pharmaceutical industry is integral to both the country’s health and growth missions, contributing £17.6 billion in direct gross value added (GVA) annually and supporting 126,000 high-skilled jobs across the nation. It also invests more in research and development (R&D) than any other sector. Yet inward life sciences foreign direct investment (FDI) fell by 58per cent, from £1,897 million in 2021 to £795 million in 2023, while pharmaceutical R&D investment in the UK lagged behind global growth trends, costing an estimated £1.3 billion in lost investment in 2023 alone.

Keep ReadingShow less